UniProt A8K1V4
Coactivator peptide src-1 HD3 (A8K1V4)
Coactivator peptide src-1 HD3 (UniProt A8K1V4): 61 experimental structures on GenesisL1, 27 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- A8K1V4
- Protein
- Coactivator peptide src-1 HD3
- Experimental structures
- 61
- Predicted models
- 0
- Pockets
- 27 · 1 record with a druggable one
Structures
61 records of A8K1V4 in the MolNFT archive: 61 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 3P88 | FXR bound to isoquinolinecarboxylic acid | x-ray diffraction | B | — | — |
| 3P88 | Fxr bound to isoquinolinecarboxylic acid | x-ray diffraction | B | — | — |
| 3P89 | FXR bound to a quinolinecarboxylic acid | x-ray diffraction | B | — | — |
| 3P89 | Fxr bound to a quinolinecarboxylic acid | x-ray diffraction | B | — | — |
| 5Q0J | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 1 (best 0.37) |
| 5Q0J | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0K | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q0L | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 1 (best 0.78) |
| 5Q0L | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0M | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q0N | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.41) |
| 5Q0N | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0O | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | — |
| 5Q0O | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0P | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.45) |
| 5Q0P | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0Q | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 1 (best 0.43) |
| 5Q0Q | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0R | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B | — | 1 (best 0.42) |
| 5Q0R | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q0S | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.38) |
| 5Q0S | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0T | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B | — | 1 (best 0.43) |
| 5Q0T | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q0U | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.41) |
| 5Q0U | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0V | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0W | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B | — | 1 (best 0.43) |
| 5Q0W | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q0X | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q0Y | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.42) |
| 5Q0Y | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q0Z | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q10 | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B | — | — |
| 5Q10 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q11 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q12 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q13 | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 1 (best 0.43) |
| 5Q13 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q14 | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.41) |
| 5Q14 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q15 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q16 | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 1 (best 0.43) |
| 5Q16 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q18 | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 1 (best 0.45) |
| 5Q18 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q19 | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q1A | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.41) |
| 5Q1A | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q1B | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q1C | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q1D | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B, D | — | 2 (best 0.39) |
| 5Q1D | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q1E | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B | — | 1 (best 0.44) |
| 5Q1E | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q1F | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D | — | — |
| 5Q1G | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B | — | — |
| 5Q1G | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B | — | — |
| 5Q1H | Ligand binding to farnesoid-X-receptor | x-ray diffraction | B, D, F, H | — | — |
| 5Q1I | Ligand binding to FARNESOID-X-RECEPTOR | x-ray diffraction | B | — | 1 (best 0.44) |
1 record more on the page itself.
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.